Prostate cancer: Radiopharmaceuticals. Part 1 - Radium-223

December 06, 2023 00:30:53
Prostate cancer: Radiopharmaceuticals. Part 1 - Radium-223
COR2ED - Oncology Medical Conversation
Prostate cancer: Radiopharmaceuticals. Part 1 - Radium-223

Dec 06 2023 | 00:30:53

/

Show Notes

Dr. Tanya Dorff (City of Hope Comprehensive Cancer Center, Los Angeles, USA) and Dr. Phillip Koo (Banner MD Anderson Cancer Center, Arizona, USA) discuss the latest developments in the field of radiopharmaceuticals and their use in Prostate Cancer. They are also joined by guest speaker Dr. Neal Shore (Carolina Urologic Research Center, North Carolina, USA).

In this first episode, the experts focus on the alpha emitter, Radium-223 which received regulatory approval on the basis of the phase 3 ALSYMPCA trial in patients with metastatic castration resistant prostate cancer (mCRPC) and symptomatic bone metastases. They consider mechanism of action and discuss key results from the trial and the safety profile.

The experts also review the ERA-223 and PEACE-III randomised trials which investigated the use of Radium-223 in combination with next generation androgen receptor inhibitors (ARIs). A number of real-world evidence studies are also reviewed as the experts consider where radium-223 fits into the overall treatment sequence for mCRPC patients. Radiation safety and general considerations for delivering therapy with radiopharmaceuticals are also discussed.

Other Episodes

Episode

December 06, 2023 00:22:49
Episode Cover

Prostate cancer: PARP inhibitors. Part 3 - Efficacy and safety of combination therapy

Dr Tanya Dorff, a Medical Oncologist from the City of Hope Comprehensive Cancer Center and Dr Neeraj Agarwal, Medical Oncologist and Director of the...

Listen

Episode

December 06, 2023 00:23:31
Episode Cover

Prostate cancer: Shared decision-making in nmCRPC

Brenda Martone, a nurse practitioner at Northwestern Medicine in Chicago Illinois and Dr Alicia Morgans, Genitourinary Medical Oncologist at the Dana-Farber Cancer Institute in...

Listen

Episode

April 25, 2024 00:27:48
Episode Cover

Câncer de pulmão: Desafios da fase pré-analítica e teste de biomarcadores

Quais são os desafios mais comuns na fase pré-analítica na luta contra o câncer de pulmão e como podemos superá-los? Qual a importância de...

Listen